Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight The SLE clinical trial analysis report delivers ...
A pivotal trial of obinutuzumab has demonstrated the strongest evidence yet of the efficacy of B-cell depletion in systemic ...
Biogen announced positive results from the Phase 2 part of the AMETHYST Phase 2/3 study (part A) of investigational therapy, ...
Investigators studied GLP-1 receptor agonist use and renal and inflammatory outcomes among patients with systemic lupus erythematosus and type 2 diabetes mellitus.
India Today on MSN
CAR-T therapy, used for cancer, shows promise in treating lupus
For patients who have spent years managing unpredictable and debilitating autoimmune conditions like lupus, the findings ...
A new study found early hydroxychloroquine (HCQ) use offers no protection against preeclampsia or preterm birth in women with systemic lupus erythematosus (SLE).
Specific SLE phenotypes, including LN and aPL positivity, may be more predictive of excess CV risk than generic risk calculators.
Objective Systemic lupus erythematosus (SLE) primarily affects women of reproductive age, necessitating complex conversations ...
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disorder in which the body’s immune system mistakenly attacks its own healthy tissues. This condition can affect multiple organs, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results